Semma Therapeutics - Ownership and Business Overview

Life ScienceCompany

Semma Therapeutics Ownership

Who owns Semma Therapeutics?

Semma Therapeutics is owned by Vertex Pharmaceuticals. It was acquired on September 3, 2019.

Was Semma Therapeutics formerly PE-backed?

Yes. Semma Therapeutics was formerly owned by 1 private investor.

Semma Therapeutics Business Overview

Where is Semma Therapeutics headquartered?

Semma Therapeutics is headquartered in Cambridge, Massachusetts.

What sector is Semma Therapeutics in?

Semma Therapeutics is a life science company.

When was Semma Therapeutics founded?

Semma Therapeutics was founded in 2015.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Semma Therapeutics

Semma Therapeutics, Inc.

100 Technology Square, Floor 3,
Cambridge, Massachusetts 02139
United States,
(857) 529-6430
www.semma-tx.com

Semma Therapeutics is a privately held biotechnology company pioneering the use of stem cell-derived human islets as a potentially curative treatment for type 1 diabetes. Semma Therapeutics was formed in 2015 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.